Search Results
Baxter Healthcare launches second Reconciliation Action Plan in conjunction with National Reconciliation Week (27 May - 3 June)
Baxter Healthcare, a global leader in medical technology, has marked the start of Reconciliation Week (May 27 – June 3) with the release of its second Reflect: Reconciliation Action Plan (RAP).
Baxter Publishes Annual Corporate Responsibility Report, Reinforcing Longstanding Commitment to Making a Meaningful Difference
Baxter International Inc. (NYSE:BAX), a global medtech leader, today published its 2022 Corporate Responsibility Report.
Baxter Healthcare announces Australia and New Zealand General Manager Steve Flynn to lead Asia Pacific region
Mr Flynn, who has served as General Manager of Baxter Australia and New Zealand since 2015, will lead the Asia Pacific region, reporting directly to Baxter International Chairman, President and Chief Executive Officer, José (Joe) E. Almeida.
Baxter Healthcare launches inaugural Reconciliation Action Plan (RAP) - Reconciliation Week May 27 – June 3
Baxter Healthcare has marked the start of Reconciliation Week (May 27 – June 3) with the launch of its first Reconciliation Action Plan (RAP). The Reflect RAP acknowledges Aboriginal and Torres Strait Islander peoples as the First Nations peoples of Australia and provides a framework to deepen Baxter Healthcare’s understanding of its sphere of influence and the unique contribution it can make to reconciliation.
Baxter Reports Fourth-Quarter and Full-Year 2021 Results
Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter and full year ended Dec. 31, 2021, and provided its financial guidance for full-year and first-quarter 2022. Fourth-quarter and full-year 2021 results reflect 19 days of contribution from Hillrom Holdings, Inc. (Hillrom) subsequent to Baxter’s acquisition of the company on Dec. 13, 2021.
Baxter Completes Acquisition of Hillrom, Creating ~$15 Billion Global Medtech Leader
Baxter International Inc. (NYSE:BAX), a global medtech leader, announced today it has completed its acquisition of Hillrom. Baxter paid $156.00 in cash for each outstanding share of Hillrom common stock for a purchase price of $10.5 billion (based on Hillrom share counts at closing). Including the assumption of Hillrom's outstanding debt obligations, the enterprise value of the transaction is approximately $12.5 billion.
Baxter to Acquire Hillrom, Expanding Connected Care and Medical Innovation Globally
Baxter International Inc. (NYSE:BAX), a leading global medical products company, and Hillrom (NYSE:HRC), a global medical technology leader, today announced that the companies have entered into a definitive agreement under which Baxter has agreed to acquire Hillrom for $156.00 per share in cash for a total equity value of approximately $10.5 billion and a total enterprise value of approximately $12.4 billion, including the assumption of debt.
Baxter Launches 2030 Corporate Responsibility Commitment to Advance Environmental, Social and Governance Priorities
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today released its 2020 Corporate Responsibility Report.
Baxter Healthcare and Micrel Medical Devices announce distribution agreement in Australia and New Zealand to support Parenteral Nutrition patients
Baxter Healthcare (Baxter), a global leader in clinical nutrition, and Micrel Medical, a medical device company specializing in infusion therapy, today announced an agreement for the distribution of the Micrel Mini Rythmic PN+ infusion pump for Parenteral Nutrition (PN).
Baxter Healthcare launches “My Kidney Journey” patient website for Chronic Kidney Disease (CKD) and Dialysis care
Baxter Healthcare (Baxter), a global leader in dialysis care, announced today the launch of a new online portal to support patients living with Chronic Kidney Disease (CKD). The new “My Kidney Journey” website launched in Australia is designed to inform patients of treatment options for Chronic Kidney Disease.